Introduction
Pesticide self-poisoning is a major global clinical problem, killing an estimated 350,000 people every year. 1 -3 The World Health Organization (WHO) has identifi ed pesticide poisoning as the single most common method of suicide worldwide. 4, 5 Organophosphorus (OP) insecticides are the most important pesticides and act through phosphorylating the active site of cholinesterases, resulting in acetylcholine build-up. 6, 7 This produces excessive cholinergic stimulation, causing clinical features in both the peripheral and central nervous systems. Carbamate insecticides are also important and produce similar effects.
Despite the widespread incidence of OP and carbamate insecticide poisoning, there has been little agreement about the best treatment. 8, 9 Therapy involves resuscitation including administration of oxygen and fl uids, support for airway and ventilation, a muscarinic antagonist (usually atropine) and, for OP poisoning, an acetylcholinesterase reactivator (usually pralidoxime or obidoxime). 10, 11 Atropine and oximes were introduced into clinical practice without clinical trials to guide their use; therefore, the best way of using these drugs is still under study.
A recent trial from Bangladesh 12 showed markedly more rapid atropinisation of OP-poisoned patients with a doubling dose regimen 13 of atropine rather than a standard bolus dose regimen. 8 The time to stabilisation was reduced from a mean of 152 min (95% CI: 130 -173) to 24 min (95% CI: 20 -28) (P Ͻ 0.001) in those receiving the doubling regimen; this faster stabilisation was associated with a mortality reduction from 22.5% to 8% (P ϭ 0.01). This study demonstrates a clear clinical benefi t achieved by administering atropine rapidly to sick patients with anticholinesterase insecticide poisoning.
However, such rapid administration of atropine is hindered by textbooks and articles stating that oxygen must be given prior to atropine due to the risk of atropine-induced ventricular tachycardia or fi brillation (Box 1). District hospitals in rural Asia, which deal with the vast majority of anticholinesterase poisoned patients, are often understaffed and inadequately equipped. 14 Many of the these hospitals do not have easy access to oxygen and this practice therefore causes a delay in administering atropine or for atropine to be withheld. This delay will result in prolonged hazardous cholinergic effects such as bronchospasm, bronchorrhoea, bradycardia and hypotension, risking the patient ' s life (Box 2).
In a literature review, we found 28 publications (14 textbooks and 14 papers) published between 1959 and 2012 that stated atropine (i) should not be given before oxygen 7,15 -31 or (ii) should ideally not be given before oxygen due to the risk of it causing ventricular dysrhythmias in hypoxic OP pesticide-poisoned patients. 32 -41 However, on inspection, only 2 of the 28 papers provided any evidence of ventricular dysrhythmias after atropine administration 32, 41 (Box 3), and neither offered even modest evidence of an association. The majority of articles provided this guidance without any reference to the literature (Fig. 1) .
The aim of this paper is to analyse the data derived from nearly 2000 Sri Lankan patients with OP or carbamate poisoning who routinely received atropine before oxygen to determine whether there is evidence of early cardiac deaths that might be due to atropinisation.
Materials and methods

Patient cohort
In order to examine the occurrence of fatal ventricular dysrhythmias after treatment with atropine, a database of all OP and carbamate pesticides-poisoned patients treated in Anuradhapura and Polonnaruwa district hospitals in Sri Lanka from 31 March 2002 to 1 September 2005 was examined. The cohort included two randomised controlled trials (RCT). 42 -44 The fi rst RCT compared multiple Hase and colleagues reported the case of a 26-year-old man who was admitted to hospital after self-poisoning with the OP insecticide diazinon. He was hypoxic, bradycardic and had pulmonary oedema and was immediately intubated. He received atropine until atropinisation: 40 mg of atropine over 30 min. Ten minutes later, he became pulseless and ECG showed ventricular tachycardia, and then ventricular fi brillation. The patient recovered after receiving a DC shock. The authors reported that atropine decreases the threshold for ventricular tacharrhythmias, by lowering the vagal tone and increasing the heart rate. 51 They also hypothesised that hypoxia, bradycardia and pulmonary oedema further lowered this threshold.
Finkelstein cases 32
This study included 53 patients with severe OP pesticide poisoning requiring ventilation and intensive care monitoring who were treated according to a standard protocol. Patients received atropine 2 mg IV at intervals of 10 min or more until bronchospasm and bronchorrhoea were controlled. Cyanotic or hypoxemic patients received short treatments of 100% oxygen, until an oxygen saturation of above 92% was confi rmed, prior to each atropine dose. 
Treatment and procedure
Patients were resuscitated following standard protocols, including evaluation of airway breathing and circulation. 13 Due to the absence of emergency departments at the time of the study in the study hospitals, patients fi rst received medical care on arrival at the medical ward. This typically delayed initial treatment by 10 min. Oxygen was not immediately available at any site of resuscitation.
Conscious patients with cholinergic signs (especially miosis, sweating, ref 13) were given an initial dose of 0.6 -1.2 mg of atropine rapidly IV; unconscious patients were treated with an initial dose of atropine 1.8 -3 mg. If after 5 min atropinisation had not occurred, a double dose was given. This doubling was continued each time that there was no response (improved heart rate and blood pressure, clear lungs). Because oxygen was rarely available on the ward and had to be brought from intensive care, protocols did not require the administration of oxygen before atropine since this would delay treatment.
Once stable, patients received activated charcoal as per their allocation during the RCT. 43 No patients in this cohort received forced emesis; patients presenting within 1 h of a potentially lethal ingestion who provided consent underwent gastric lavage.
Patients were resuscitated with fl uids to ensure adequate fl uid output and ventilated as necessary. Symptomatic patients also received 1 g of pralidoxime chloride every 6 h for 1 -3 days or, if they were recruited to the pralidoxime RCT, they received either placebo or 2 g of pralidoxime chloride over 20 min followed by 0.5 g/hr until death, they had no further need for atropine, or 7 days. 44 Sick patients were placed on a cardiac monitor (including oxygen saturation monitoring) for several hours after arrival in the ward; due to a lack of intensive care beds, the majority of patients were managed on the open ward for the fi rst few hours to days. Temporary pacemakers were not used for these patients.
Patients were seen by study doctors soon after their admission to the medical ward, frequently while unstable in the fi rst few hours, and then twice daily on ward rounds. They were also called to see the patient whether any events occurred. Events, such as endotracheal intubation, seizures, cardiorespiratory arrests or death, were recorded at the time of the event and entered into a prospective database. We used the incidence of fatal primary cardiac arrests as a sensitive (but non-specifi c) marker of likely ventricular dysrhythmias.
Analysis
Administration of suffi cient atropine to resuscitate and stabilise patients on admission in this series takes an estimated 23.4 mg (range: 1 -75) of atropine within half an hour. 8 The recent Bangladeshi trial reported a mean time of 24 min (95% CI: 20 -28) for this regimen in 69 patients. We hypothesised that atropine-induced dysrhythmias would likely occur within the fi rst hour of atropine administration. To be conservative we therefore looked for any OP or carbamate pesticide patients dying from a primary cardiac arrest within 3 h of admission. If atropine-induced ventricular dysrhythmias are a serious problem, we would expect to see evidence of such deaths. Fig. 1 . Publications linked to the references they cite to underpin this guidance. Circles within the black rectangle : the 28 publications found to state this guidance. By colour: blue , without supporting citations; orange, provide non-relevant supporting citations; green , provide relevant supporting citations. Outside the rectangle , in squares , cited human publications that are not relevant: in light blue , primary OP pesticide papers; in red , primary cardiac disease papers; in purple , primary nerve agent papers. Triangles : animal studies. Numbers correspond with the references. Publications from the same book, with a different edition, are placed together (refs 27 and 29, and 38 and 39) . Of the 28 publications, 11 cited a source for their statement while 17 did not provide any supporting evidence. The 11 publications cited 18 sources on 27 occasions. Eleven citations were to relevant but secondary sources 18, 20, 22, 24, 26, 29, 38 while seven citations were of irrelevant primary or secondary sources (patients with myocardial infarctions, nerve agent studies, or patients with pesticide poisoning but no ventricular dysrhythmias 10,53,62 -64 ). Animal studies with OP nerve agents, pesticide active ingredients, or myocardial infarctions 51, 54, 55, 58, 59 were cited on eight occasions (colour version of this fi gure can be found in the online version at www.informahealthcare.com/ctx).
We examined the database for deaths of OP and carbamate insecticide-poisoned patients and plotted the time from admission to death. We then identifi ed those patients who died from a respiratory or cardiac arrest, plotting for the latter group the interval from admission to death. Because some patients had cardiac arrests following respiratory arrests, we classifi ed primary cardiac arrests as occurring more than 2 h after any respiratory arrest.
The analysis included all patients who presented to the two study secondary hospitals. None were transferred out to other hospitals. Many patients were transferred from surrounding primary hospitals where symptomatic patients would have received atropine.
Statistics
The primary data analysis was performed in GraphPad Prism (version 5). Demographic factors and clinical characteristics were summarised using counts (percentages) for categorical variables and the median [interquatile range (IQR)] for non-normally distributed continues variables.
Results
The database contained details of 1957 patients with OP and carbamate pesticide poisoning admitted to hospital between 31 March 2002 and 1 September 2005. Out of these patients, 49.7% were transferred from surrounding peripheral hospitals after administration of atropine.
In total 222 (11.3%) patients died. Eight were excluded from the analysis because they died on arrival in the ward, before atropine could be given. Cardiac arrest was recorded, most often in combination with a respiratory arrest, for 136 patients. Fifty-fi ve had a primary cardiac arrest as cause of death. Baseline demographic and clinical characteristics of all patients who died and those dying from primary cardiac arrests are presented in Table 1 .
For all 214 deaths of OP and carbamate-poisoned patients receiving atropine, 22 (10.3%) occurred within the fi rst 3 h (22/1957, 1.1%; Fig. 2, Table 2 ). Only six occurred within the fi rst hour and half of these were due to dimethoate-induced distributive cardiovascular shock. 45 Of the 55 primary cardiovascular deaths, only 1 (1.8%) occurred within the fi rst hour and 4 occurred within the fi rst 3 hours (7.3%). The incidence for a primary cardiac death within 3 h of atropine administration, and thereby an estimate for the maximum rate of fatal ventricular arrhythmia, was 4/1957 (0.2%).
Discussion
The weak published evidence for atropine-induced ventricular dysrhythmias in anticholinesterase poisoning is supported by our analysis of the largest cohort of OP and carbamatepoisoned patients published. In this Sri Lankan cohort, routinely treated with atropine before oxygen, the incidence of death from cardiac arrest during the fi rst 3 hours of hospital admission was 0.2%. It is possible that the actual incidence of (non-fatal) ventricular dysrhythmias was higher than this; however, the data indicate that serious atropine-induced dysrhythmias are not a major clinical problem.
The common advice that oxygen should be given before atropine after OP poisoning due to the risk of ventricular dysrhythmias is based upon a single case report. This lack of evidence is startling in the face of the estimated two mil- IQR, interquartile range. Data are number (%) or otherwise indicated. Data were collected on admission to hospital; recruitment occurred soon after. * Other OP insecticides included: diazinon, malathion, oxydemeton-methyl, phenthoate, profenofos, prothiofos, and quinalphos. † Carbamates included: carbosulfan and fenobucarb.
lion cases of OP or carbamate poisoning that have occurred each year for the last 20 -30 years. The majority of articles offering this guidance appear to have made it without any reference to the literature, resulting in the guidance being copied from article to article, review to review. Sadeeh, 46 Karki, 47 and colleagues studied the cardiac and electrocardiographic manifestations of acute OP poisoning in two case series. They reported that hypoxaemia, electrolyte derangements, and acidosis were predisposing factors for the development of cardiac complications. However, neither study found a correlation between administration of high doses of atropine and ventricular dysrhythmias. Of note, the fi rst ECGs were usually taken before resuscitation and administration of oxygen or atropine, causing a delay in atropine administration that was likely hazardous to patients and ethically questionable. Ludomirsky 37 studied the occurrence of Q-T prolongation and torsade de pointes in OP pesticide-poisoned patients, reporting Q-T prolongation in 14 of 15 cases and 6 tachydysrhythmias. However, these dysrhythmias were unrelated to the use of atropine.
Rapid administration of atropine can be life-saving. 12 The evidence reported here indicates that its administration should not be held back by the lack of oxygen therapy, since atropine will reduce fl uid in the lungs and improve oxygenisation 45 as well as treat hypotension and bradycardia. We recommend that oxygen is provided as soon as possible to all moderate-to-severely poisoned patients but that its absence does not slow or prevent the provision of atropine. This guidance was already given by Fernando in 1989 35 and was implicit in the key review published by Namba in 1971. 10 It has become more commonplace over the last few years. 48, 49 The recommendation for provision of oxygen before atropine has been in the cardiology literature since the 1970s. There is evidence to show that atropine can have adverse effect in patients following cardiac complications such as myocardial infarction. 50 -53 However, we have been unable to fi nd any discussion comparing the focal ischaemia found in myocardial infarction with the global ischaemia found in pesticide poisoning. The relevance of these data to young previously fi t patients with normal hearts and anticholinesterase poisoning seems less certain.
Contrary to the very limited human data, fi ve animal studies have been published. However, only two looked at pesticide poisoning 54,55 and these were with unformulated TEPP 
Limitations
This prospective dataset documented only whether and when a patient had had a cardiac arrest or respiratory arrest.
Resources were limited in the hospitals and patients were rarely treated in an intensive care unit where continual cardiac monitoring and observation could take place. However, initial atropinisation was done by a research team with sick patients on a cardiac monitor so dysrhythmias would have been noted in these early stages. No patients were reported to die from ventricular dysrhythmias and there was no sense that atropine administration was hazardous in the absence of oxygen. Many of the patients were transferred from peripheral hospitals where they had received atropine. This would have improved the clinical condition of some patients and reduced the risk of complications. However, all patients were assessed during resuscitation at the secondary hospitals for cholinergic signs and the majority required atropine. The analysis does not include patients who died between presentation at the primary hospital and arrival in the medical wards of the study secondary hospital.
Conclusion
Adequate atropinisation is key for the management of OP and carbamate poisoning and should be done early, with appropriate titration and monitoring of developing adverse events. Currently, we can fi nd no evidence to support the claim that oxygen must be given before atropine. It is likely that in hospitals where oxygen is not available, early administration of atropine during resuscitation is life-saving. 12 Guidelines for management of OP and carbamate poisoning should recommend early atropinisation of patients, whether oxygen is available or not.
